Company Filing History:

15 out of 1,678

Degussa Aktiengesellschaft

patents

Years Active: 2001-2012

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8334126 - Coryneform host-vector systems comprising a chromosomal ALR gene which is attenuated or eliminated and methods of using (2012-12-18),

2. 8048665 - Nucleotide sequences encoding alanine racemase from coryneform (2011-11-01),

3. 7491521 - Rhodococcus nitrile hydratase (2009-02-17),

4. 7348037 - Sulfur-containing animal-feed additives (2008-03-25),

5. 7288402 - Rhodococcus nitrile hydratase (2007-10-30),

6. 6958228 - Nucleotide sequence which code for the metH gene (2005-10-25),

7. 6942996 - Isolated polynucleotide from Corynebacterium encoding a homocysteine methyltransferase (2005-09-13),

8. 6939695 - Nucleotide sequences which code for the rpsL gene (2005-09-06),

9. 6913908 - Methods of making L-amino acids in coryneform using the sigE gene (2005-07-05),

10. 6822085 - Nucleotide sequences which code for the cysD, cysN, cysK, cysE and cysH genes (2004-11-23),

11. 6815196 - Nucleotide sequences encoding o-succinylhomoserine sulfhydrylase (2004-11-09),

12. 6812016 - Nucleotide sequences which code for the metY gene (2004-11-02),

13. 6783967 - Nucleotide sequences which code for the rpoB gene (2004-08-31),

14. 6759224 - Nucleotide sequences which code for the sahH gene (2004-07-06),

15. 6596327 - Pourable feed additives containing D-pantothenic acid and/or salts thereof, and process for their preparation (2003-07-22),

Title: **Innovative Contributions of Michael Binder in Biotechnology**

Introduction

Michael Binder, based in Steinhagen, Germany, is a prominent inventor known for his significant contributions to biotechnology. With an impressive portfolio of 22 patents, he has been instrumental in advancing the field through innovative research and applications.

Latest Patents

Among Michael Binder's notable patents are advancements in coryneform host-vector systems, specifically one that focuses on the chromosomal ALR gene, which is either attenuated or eliminated. This invention relates to an isolated polynucleotide that codes for the alr gene and a host-vector system utilizing a coryneform host bacterium. This groundbreaking work also involves a vector carrying the alr gene and highlights the use of specific polynucleotides as hybridization probes. Another patent details nucleotide sequences encoding alanine racemase from coryneform, showcasing Binder's commitment to enhancing biotechnological processes through detailed molecular insights.

Career Highlights

Michael Binder's career has been marked by his association with key industry players. He has transacted his expertise at esteemed companies such as Degussa Aktiengesellschaft and Evonik Degussa GmbH. During his tenure, he has focused on creating impactful solutions that can propel advancements in various applications across the biotech field.

Collaborations

Collaboration has played a significant role in Binder's career. He has worked alongside accomplished colleagues such as Walter Pfefferle and Georg Thierbach, who share his vision for innovation in biotechnology. These partnerships have fostered a constructive environment for research and development, leading to significant scientific breakthroughs.

Conclusion

Michael Binder exemplifies the spirit of innovation in the biotechnology sector. His contributions through his patents and collaborations highlight a robust commitment to improving methodologies and technologies that have far-reaching implications. As he continues to advance research, the impact of his work will undoubtedly resonate within the scientific community and beyond.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com